NRIX
Nurix Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -1.4% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | +2 | 57.55M | $1.40B | +9 | −7 |
| Q1 2026 | 81 | +9 | 58.06M | $899.96M | +14 | −5 |
| Q4 2025 | 72 | -4 | 55.79M | $1.06B | — | −4 |
| Q3 2025 | 18 | +1 | 36.35M | $335.90M | +1 | — |
| Q2 2025 | 14 | -2 | 38.82M | $442.11M | — | −2 |
| Q1 2025 | 13 | 0 | 15.31M | $181.88M | +1 | −1 |
| Q4 2024 | 13 | -1 | 15.53M | $292.61M | +1 | −2 |
| Q3 2024 | 13 | -1 | 13.04M | $292.98M | +1 | −2 |
| Q2 2024 | 14 | — | 12.64M | $263.85M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.19M | -11.1% | $37.88M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 3.19M | -11.1% | $37.88M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.19M | -11.1% | $37.88M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.19M | -11.1% | $37.88M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.19M | -11.1% | $37.88M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.19M | -11.1% | $37.88M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.19M | -11.1% | $37.88M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 2.91M | -3.1% | $34.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 2.91M | -3.1% | $34.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (passiv) | 2.86M | +2.1% | $33.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passiv) | 1.72M | +8.8% | $20.49M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passiv) | 1.72M | +8.8% | $20.49M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | ARK Investment Management ✦ | 1.59M | +4.0% | $18.90M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 1.32M | +54.7% | $15.65M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 1.32M | +54.7% | $15.65M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Millennium Management ✦ | 874.40K | +106.2% | $10.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 257.52K | +90.6% | $3.06M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | PRIMECAP Management ✦ | 232.00K | 0.0% | $2.76M | 0.0% | Held | 4 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 218.45K | -75.0% | $2.60M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 59.92K | -46.9% | $711,885 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Renaissance Technologies ✦ | 59.50K | Neu | $706,860 | 0.0% | New | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 11.67K | -83.5% | $138,615 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 11.67K | -83.5% | $138,615 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 11.67K | -83.5% | $138,615 | 0.0% | ▼ Trim | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Renaissance Technologies | $706,860 | 0.0% |
Ausgestiegen
| Norges Bank | $6.01M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 194 Inhaber, 116.98M Anteile, $1.75B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.